Pharmacokinetics and metabolism of dantrolene in horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 34, Issue 3, 2011, Pages 238-246

  DiMaio Knych, Heather K ^a   Arthur, R M ^b   Taylor, A ^a   Moeller, B C ^a   Stanley, S D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYDANTROLENE; CYTOCHROME P450; DANTROLENE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG TISSUE LEVEL; FEMALE; HORSE; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ANIMALS; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DANTROLENE; FEMALE; HORSES; MALE; MASS SPECTROMETRY; MICROSOMES, LIVER; MUSCLE RELAXANTS, CENTRAL; OINTMENTS; RANDOM ALLOCATION; TIME FACTORS;

EQUIDAE;

EID: 79960199599     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01214.x     Document Type: Article

References (8)

1. Court, M.H., Engelking, L.R., Dodman, N.H., Anwer, M.S., Seeler, D.C. & Clark, M. (1987) Pharmacokinetics of dantrolene sodium in horses. Journal of Veterinary Pharmacology and Therapeutics, 10, 218-226.
2. Edwards, J.G.T., Newton, J.R., Ramzan, P.H.L., Pilsworth, R.C. & Shepherd, M.C. (2003) The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the thoroughred racehorse. Equine Veterinary Journal, 35, 707-710.
3. Hollifield, R.D. & Conklin, J.D. (1973) Determination of dantrolene in biological specimens containing drug-related metabolites. Journal of pharmaceutical sciences, 62, 271-274.
4. Jayyosi, Z., Villoutreix, J., Ziegler, J.M., Batt, A.M., DeMaack, F., Siest, G. & Thomas, P.E. (1993) Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes. Drug Metabolism and Disposition, 21, 939-945.
5. Krause, T., Gerbershagen, M.U., Fiege, M., WeiBhorn, R. & Wappler, F. (2004) Dantrolene-A review of its pharmacology, therapeutic use and new developments. Anaesthesia, 59, 364-373.
6. McKenzie, E.C., Valberg, S.J., Godden, S.M., Finno, C.J. & Murphy, M.J. (2004) Effect of oral administration of dantrolene sodium on serum creatinine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis. American Journal of Veterinary Research, 65, 74-79.
7. Omura, T. & Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370-2378.
8. Wuis, E.W., Vree, T.B. & Van Der Kleijn, E. (1990) Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs. International journal of clinical pharmacology research, 10, 203-210.